Publications (30 results)
Please use discretion when following external links; Assaypro cannot guarantee the validity and security of all citation links provided.* Angarita-Diaz MP (2021) Evaluation of possible biomarkers for caries risk inchildren 6 to 12 years of age. J Oral Microbiol. 13(1):1956219.
* Suman S et al. (2016) Quantitative proteomics revealed novel proteins associated with molecular subtypes of breast cancer. J Proteomics. 148:183-93.
* Salem NA et al. (2016) Nanofiber-expanded stem cells mitigate liver fibrosis: Experimental study. Tissue Cell. 48(5):544-51.
* Ajibola SO et al. (2016) Utility of a single mid-trimester measurement of plasminogen activator Type 1 and fibronectin to predict preeclampsia in pregnancy. Nigerian Medical Journal 57 (4):213-216
* Dowling P et al. (2014) Transferrin-bound proteins as potential biomarkers for advanced breast cancer patients.BBA Clinical. 2:24-30.
* Hung TJ et al. (2013) shRNA for Thymic Stromal Lymphopoietin: A Novel Therapeutic Approach for Pulmonary Fibrosis. J Cell Sci Ther 4(3):1000144
* Ahmed SA et al. (2013) Immunobiochemical parameters as differential factors between colorectal cancer and its association with intestinal schistosomiasis. World Journal of Pharmaceutical research 2(6):1913-1927
* Zhou T et al. (2012) Implication of dysregulation of the canonical wingless-type MMTV integration site (WNT) pathway in diabetic nephropathy. Diabetologia. 55(1):255-66
* Lsin M et al. (2012) Analysis of p53 Tumor Suppressor Pathway Genes in Chronic Lymphocytic Leukemia. DNA Cell Biol. 31(5):777-782
* Yang YL et al. (2011) BMP-2 suppresses renal interstitial fibrosis by regulating epithelial-mesenchymal transition. J Cell Biochem. 112(9):2558-65.
* Schledzewski K et al. (2011) Deficiency of liver sinusoidal scavenger receptors stabilin-1 and -2 in mice causes glomerulofibrotic nephropathy via impaired hepatic clearance of noxious blood factors. J Clin Invest. 121(2):703-714
* Rapuano BE and MacDonald DE (2011) Surface oxide net charge of a titanium alloy: modulation of fibronectin-activated attachment and spreading of osteogenic cells. Colloids and surfaces B Biointerfaces 82(1):95-103
* Hamed S et al. (2011) Fibronectin Potentiates Topical Erythropoietin-Induced Wound Repair in Diabetic Mice. J Invest Dermatol. 131:1365-1374
* Zhang B et al. (2010) Inhibition of Connective Tissue Growth Factor Overexpression in Diabetic Retinopathy by SERPINA3K via Blocking the WNT/beta-Catenin Pathway. Diabetes. 59(7):1809-1816
* Xie P et al. (2010) Pathobiology of renal-specific oxidoreductase/myo-inositol oxygenase in diabetic nephropathy: its implications in tubulointerstitial fibrosis. Am J Physiol Renal Physiol. 298(6):F1393-404
* Mathes SH et al. (2010) A bioreactor test system to mimic the biological and mechanical environment of oral soft tissues and to evaluate substitutes for connective tissue grafts. Biotechnol Bioeng. 107(6):1029-1039
* Dief A and Zahran SM (2009) Fibronectin and interleukin-18 in renal ischemia with and without reperfusion in rats. Bull. Alex. Fac. Med. 45:253-260
* Abeer AS et al. (2009) Antemortem and Postmotem Extimation of Skin Wound Age in Rats: Biochemical Study. Bull. Alex. Fac. Med. 45:241-251.
* Fleenor DL et al. (2008) Inhibitors of protein kinase c-delta for the treatment of glaucoma. USPTO Patent Applicaton #: 20080153903
* Wordinger RJ et al. (2007) Effects of TGF-beta2, BMP-4, and Gremlin in the Trabecular Meshwork: Implications for Glaucoma. Investigative Ophthalmology and Visual Science 48:1191-1200
* Wei JL et al. (2007) Synergistic effects of pravastatin and pioglitazone in renal tubular epithelial cells induced by transforming growth factor-beta1. Cell Biol Int. 31(5):451-458
* Wang R et al. (2007) Emodin suppresses interleukin-1beta induced mesangial cells proliferation and extracellular matrix production via inhibiting P38 MAPK. Life Sciences 80(26):2481-2488
* Zhang SX et al. (2006) Therapeutic Potential of Angiostatin in Diabetic Nephropathy. J Am Soc Nephrol. 17(2):475-486
* Wang JJ et al. (2006) Salutary effect of pigment epithelium-derived factor in diabetic nephropathy: evidence for antifibrogenic activities. Diabetes 55:1678-1685
* Shimizu M et al. (2006) Endothelin(B) receptor blocker inhibits high glucose-induced synthesis of fibronectin in human peritoneal mesothelial cells. Peritoneal Dialysis International 26(3):393-401
* Haiping Z et al. (2006) Prevention of radiation-induced pneumonitis by recombinant adenovirus-mediated transferring of soluble TGF-beta type II receptor gene. Cancer Gene Ther. 13(9):864-872
* Fleenor DL et al. (2006) TGFbeta2-Induced Changes in Human Trabecular Meshwork: Implications for Intraocular Pressure. Invest. Ophthalmol. Vis. Sci. 47(1): 226-234
* Wang JJ et al. (2005) Decreased expression of pigment epithelium-derived factor is involved in the pathogenesis of diabetic nephropathy. Diabetes. 54(1):243-250
* Ma JX (2005) Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same. United States Patent Applicatrion: US20050143300 A1
* Shirato K et al. (2003) Thrombin stimulates production of fibronectin by human proximal tubular epithelial cells via a transforming growth factor-beta-dependent mechanism. Nephrol Dial Transplant. 18(11): 2248-2254